BALAXI PHARMACEUTICALS LIMITED — Important, 05-11-2024: Financial Result Updates

Balaxi Pharmaceuticals Limited's Board of Directors approved the unaudited standalone and consolidated financial results for the half-year ending September 30, 2024. The company reported standalone total income of ₹220.47 crore and a net profit of ₹16.16 crore. The Board also announced the resignation of Mr. Mahesh Inani as Company Secretary and appointed Mr. Mohith Kumar Khandelwal to the position effective November 06, 2024. Detailed financial results and additional information are available on the company’s website.